eric j. kunkel, et al . assay and drug development technologies vol 2, num 4, 2004

3
Rapid Structure-Activity and Selectivity Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell- Analysis in Complex Human Primary Cell- Based Models Based Models Eric J. Kunkel, Eric J. Kunkel, et al et al . . ASSAY and Drug ASSAY and Drug Development Technologies Vol 2, Num 4, Development Technologies Vol 2, Num 4, 2004 2004 Presented by Ankit Garg Presented by Ankit Garg

Upload: lovey

Post on 06-Jan-2016

39 views

Category:

Documents


0 download

DESCRIPTION

Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based Models. Eric J. Kunkel, et al . ASSAY and Drug Development Technologies Vol 2, Num 4, 2004 Presented by Ankit Garg. The Problem. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Eric J. Kunkel,  et al .  ASSAY and Drug Development Technologies Vol 2, Num 4,  2004

Rapid Structure-Activity and Selectivity Analysis Rapid Structure-Activity and Selectivity Analysis of Kinase Inhibitors by BioMAP Analysis in of Kinase Inhibitors by BioMAP Analysis in Complex Human Primary Cell-Based ModelsComplex Human Primary Cell-Based Models

Eric J. Kunkel, Eric J. Kunkel, et alet al. . ASSAY and Drug ASSAY and Drug Development Technologies Vol 2, Num 4, Development Technologies Vol 2, Num 4, 20042004

Presented by Ankit GargPresented by Ankit Garg

Page 2: Eric J. Kunkel,  et al .  ASSAY and Drug Development Technologies Vol 2, Num 4,  2004

The ProblemThe Problem

Protein kinases are attractive drug Protein kinases are attractive drug targets because of their central role in targets because of their central role in controlling signaling pathways in all cells.controlling signaling pathways in all cells.

Kinase inhibitors tend to interact with the Kinase inhibitors tend to interact with the ATP-binding pocket and thus tend to ATP-binding pocket and thus tend to inhibit multiple targets.inhibit multiple targets.

Page 3: Eric J. Kunkel,  et al .  ASSAY and Drug Development Technologies Vol 2, Num 4,  2004

BioMAP ProcessBioMAP Process